APA (7th ed.) Citation

I, L., G, A. V. C., L, B., RF, R., Y, G., A, B., . . . MG, F. (2024). GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant. Cancer cell. https://doi.org/10.1016/j.ccell.2024.08.006

Chicago Style (17th ed.) Citation

I, Liu, et al. "GABAergic Neuronal Lineage Development Determines Clinically Actionable Targets in Diffuse Hemispheric Glioma, H3G34-mutant." Cancer Cell 2024. https://doi.org/10.1016/j.ccell.2024.08.006.

MLA (9th ed.) Citation

I, Liu, et al. "GABAergic Neuronal Lineage Development Determines Clinically Actionable Targets in Diffuse Hemispheric Glioma, H3G34-mutant." Cancer Cell, 2024, https://doi.org/10.1016/j.ccell.2024.08.006.